United States Patent and Trademark Office issues patent to Heliae

Posted On: January 12, 2012

Heliae, an Arizona-based algae technology company, announced today three significant additions to its expanding portfolio of intellectual property.

The United States Patent and Trademark Office issued patent number 8,084,038 to Heliae entitled “Methods of and Systems for Isolating Nutraceutical Products from Algae” on December 27, 2011. Heliae has received a Notice of Allowance from the USPTO for two additional patent applications focused on Heliae’s breakthrough extraction technology. These patents are expected to issue in the first half of February.

More info

From Issue 15 • Categories: Tags: algae, Aquapreneur, DHA, EPA, functional ingredients, Heliae, marine biotechnology, microalgae, nutraceutical, omega 3 • No Comments

NZ Biotech company Photonz successfully transfers omega-3 fermentation process to industrial scale Canadian pilot plant

Posted On: November 27, 2011

Biotech company Photonz Corporation has achieved a major milestone on the path to commercially manufacturing, by fermentation, the high-value omega-3 fatty acid, eicosapentaenoic acid (EPA). It has successfully transferred its strain and fermentation process, developed in Auckland, to a contract facility in Canada, which has then used that process to ferment material from algal biomass in a 7.5 tonne industrial scale reactor. This demonstrates the feasibility of commercial production of EPA from marine microalgae.

The Canadian facility has a battery of reactors and support utilities that enable it to operate multi-tonne scale fermentations under industrial conditions. During the project it produced sufficient biomass for Photonz to complete development of the downstream purification processes for its EPA product, also at pilot industrial scale.

More info

 

From Issue 15 • Categories: Tags: algae, Aquapreneur, bioprocessing, DHA, EPA, fermentation, fish oil, marine drugs, marine ingredients, microalgae, omega 3, Photonz Corporation • No Comments

Pharma Marine Launches Oceans Superior Omega-3 Ingredients

Posted On: October 14, 2011

Pharma Marine, manufacturer of high-quality, specialty omega-3 fatty acid ingredients, has introduced the Oceans omega-3 line. Oceans omega-3s combine an ecologically-focused sourcing strategy with cutting-edge processing technology to deliver best-in-class omega-3 ingredients. The raw materials used in Oceans are certified EU human food grade and utilizes several species (all Ph. Eur. monograph approved) in order to minimize the burden on any single marine resource.

In discussing the new Oceans line with Leif Gjendemsjø, founder and Managing Director of Pharma Marine, he explained, “Our goal with the Oceans line is to use the trimmings from seafood processing, which occurs before seafood reaches restaurants and stores. In the interest of sustainability, we believe that using these byproducts, which would have otherwise been wasted, is preferable to using targeted fish that are exclusively sourced for omega-3 production.”

More info

From Issue 15 • Categories: Tags: Aquapreneur, DHA, EPA, fish oil, functional ingredients, marine biotechnology, omega 3, Pharma Marine, seafood byproducts • No Comments

Source-Omega Launches Algae DHA Brand CereNate™ a Mother’s Gift for Life

Posted On: October 14, 2011

Source-Omega, a leader in international algae oil omega-3 fatty acid supplements, finished product development and private labelling, today announced creation and launch of the CereNate™ DHA brand.

To assist with the launch, Source-Omega provides exclusive marketing and distribution rights under Source-Omega’s license and sole-source agreements to Novamed Singapore, starting January 1st 2012.

“CereNate is A Mother’s Gift For Life,” said Mr Tiang Sung Ann, Director of Sales and Marketing at Novamed. Singapore has a growing economy with clinics serving Halal preferred populations seeking vegetarian capsules for omega-3 oils. CereNate conforms to international standards to provide 300mg DHA for pregnant and nursing women. In Singapore, it will be the first DHA product made entirely from plant-based sources. Tiang and Novamed bring ten years of corporate experience serving the omega-3 markets in Singapore.

More info

From Issue 15 • Categories: Tags: algae, Aquapreneur, CereNate, DHA, EPA, fish oil, marine biotechnology, marine ingredients, microalgae, omega 3, seafood byproducts, Source-Omega • No Comments

AlgaeTek Begins Development of Algae Facility in Texas

Posted On: October 6, 2011

oca Raton, FL-based Atlas Capital Holdings Inc. has announced that its wholly owned subsidiary, AlgaeTek Systems, Inc, has commenced development of its new high grade algae production facility located in Woodlands, TX.

“The facility is on track to be in production in the next six weeks,” said Christopher Davies, CEO of Atlas Capital Holdings. “We believe we will be able to harvest high-grade algae that will sell for an estimated $2,000 to $7,000 per pound. After its first year of generating revenue we will utilize our experience and expertise to develop another facility on a much larger scale.”

More info

 

From Issue 15 • Categories: Tags: algae, AlgaeTek Systems, Aquapreneur, biodiesel, biofuel, biomaterials, bioprocessing, DHA, EPA, functional ingredients, microalgae, nutraceutical, seaweed • No Comments

Neptune Technologies & Bioressources Obtains New Patent Directed to Compositions of Omega-3 Fatty Acid Phospholipids Including Krill Oil

Posted On: October 6, 2011

Neptune Technologies and Bioressources Inc., announces that the U.S. Patent and Trademark Office (“USPTO”) has granted Neptune a new patent covering omega-3 phospholipids comprising polyunsaturated fatty acids, one of the main bioactive ingredients in all recognized Krill Oils. The patent is granted for the U.S. market and is valid until 2025.

Neptune’s recently issued U.S. patent (U.S. No. 8,030,348) covers, regardless of the extraction process, novel omega-3 fatty acid phospholipid compositions suitable for human consumption, synthetic and/or natural, including compositions extracted from marine and aquatic biomasses. The 8,030,348 patent protects Neptune Krill Oil (NKO(R)) and also covers amongst others, oils and powders extracted from krill, containing marine phospholipids bonded to EPA and/or DHA, distributed and/or sold in the U.S. market.

More info

From Issue 15 • Categories: Tags: Aquapreneur, DHA, EPA, fish oil, krill oil, Neptune Technologies & Bioresources, omega 3 • No Comments

Global omega-3 market set for ongoing 15-20% growth: Report

Posted On: August 16, 2011

The 2010 global omega-3 market – just for foods and beverages and food supplements – is worth €5.57bn, according to a new report, with growth predicted of between 15-20%.

The omega-3 sector continues to expand, according to Packaged facts data.

Packaged Facts said the food, beverages and supplements figure, which excludes fish, represented a 17% rise on 2009.

“This sector continues to show strong growth, although annual growth rates are naturally moderating downward from the explosive gains seen in 2004 and 2005,” Packaged Facts observed.

In 2003, global sales of such products sat at €685m which jumped to €1.4bn in 2004 and then €2.4bn in 2005.

Although growth rates have slowed since those peak years, Packaged Facts said it was far from overcrowded or saturated and predicted annual growth of 15-20% through 2015.

More info

From Issue 15 • Categories: Tags: Aquapreneur, DHA, EPA, fish oil, functional ingredients, marine ingredients, omega 3 • No Comments

Seaweed may provide new source of functional ingredients

Posted On: July 22, 2011

Seaweed and other macroalgae could rival milk products as sources of functional ingredients such as heart healthy bioactive peptides, according to a new study. 

The review of almost 100 scientific studies, published in the Journal of Agricultural and Food Chemistry, reports that some seaweed proteins have the same effects as the bioactive peptides found in milk products and dairy products, and work to reduce blood pressure in a similar way to ACE inhibitor drugs.

“Due to the environment in which they grow, macroalgae produce unique and interesting biologically active compounds,” said Maria Hayes and colleagues from Teagasc Food Research Centre, Ireland and the University of London, UK.

“The variety of macroalga species and the environments in which they are found and their ease of cultivation make macroalgae a relatively untapped source of new bioactive compounds, and more efforts are needed to fully exploit their potential for use and delivery to consumers in food products,” they added.

More info

 

From Issue 15 • Categories: Tags: Aquapreneur, Bioactive peptides, DHA, EPA, functional ingredients, macroalgae, marine ingredients, Marine organisms, nutraceutical, seaweed, Teagasc Food Research Centre • No Comments

Aurora Algae edges closer to omega-3 EPA commercialization

Posted On: June 28, 2011

California’s Aurora Algae has signed off on the engineering contract for its commercial facility in Western Australia, as the company edges towards the production of thousands of tonnes of algae-based biomass annually.

The company announced this week that MWH and John Holland (JH) have been awarded the initial engineering contract, a move which is claimed to represent the start of the construction of the largest commercial scale photosynthetic algae facility in the world.

“Aurora Algae is now the first global company to begin a commercial project for bioproduct and biofuel production based on photosynthetic marine microalgae,” said Greg Bafalis, CEO of Aurora Algae.

More info

From Issue 14 • Categories: Tags: algae, alternative energy, Aquapreneur, Aurora Algae, DHA, EPA, functional ingredients, microalgae, omega 3 • No Comments

Marine MUFAs may improve metabolic syndrome: Mouse study

Posted On: June 14, 2011

Long-chain monounsaturated fatty acids from fish sources may improve insulin sensitivity and reduce risk factors associated with metabolic syndrome, according to new research in mice.

The study, published in the Journal of Agricultural and Food Chemistry, reports that blood plasma glucose, insulin, and lipid concentrations are enhanced, whilst insulin sensitivity is improved in mice fed a diet rich in marine derived long-chain monounsaturated fatty acids (MUFAs).

“This study demonstrates that fish-oil-derived MUFA ingestion reduces insulin resistance, as judged by the insulin tolerance test, and attenuates metabolic syndrome by improving hyperglycemia, hyperinsulinemia, and hyperlipidemia,” wrote the study authors, led by Zhi-Hong Yang, from the Tokyo Innovation Center, Japan.

“Furthermore, intake of MUFA decreased obesity-induced inflammation by suppressing … inflammatory marker genes and arachidonic acid levels, thereby possibly, in turn, reducing insulin resistance in diet-induced obese mice,” they added.

More info

From Issue 14 • Categories: Tags: Aquapreneur, blood plasma glucose, DHA, EPA, fish oil, fish protein, functional ingredients, marine extract, marine ingredients, MUFA, Tokyo Innovation Center • No Comments

« Older Entries